Compile Data Set for Download or QSAR
Report error Found 334 Enz. Inhib. hit(s) with all data for entry = 9655
TargetOrexin/Hypocretin receptor type 1(Human)
Astrazeneca

US Patent
LigandPNGBDBM479289(US10894789, Compound 233)
Affinity DataIC50: 1nMAssay Description:Measurement of [Ca2+]i using a FLIPR: CHO OX1 or CHO OX2 cells were seeded into black-walled clear-base 384-well plates (Corning, catalog #3712) at a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/14/2021
Entry Details
US Patent

TargetOrexin/Hypocretin receptor type 1(Human)
Astrazeneca

US Patent
LigandPNGBDBM479267(US10894789, Compound 66)
Affinity DataIC50: 1nMAssay Description:Measurement of [Ca2+]i using a FLIPR: CHO OX1 or CHO OX2 cells were seeded into black-walled clear-base 384-well plates (Corning, catalog #3712) at a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/14/2021
Entry Details
US Patent

TargetOrexin/Hypocretin receptor type 1(Human)
Astrazeneca

US Patent
LigandPNGBDBM479282(US10894789, Compound 221)
Affinity DataIC50: 2nMAssay Description:Measurement of [Ca2+]i using a FLIPR: CHO OX1 or CHO OX2 cells were seeded into black-walled clear-base 384-well plates (Corning, catalog #3712) at a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/14/2021
Entry Details
US Patent

TargetOrexin/Hypocretin receptor type 1(Human)
Astrazeneca

US Patent
LigandPNGBDBM479203(US10894789, Compound 78)
Affinity DataIC50: 2nMAssay Description:Measurement of [Ca2+]i using a FLIPR: CHO OX1 or CHO OX2 cells were seeded into black-walled clear-base 384-well plates (Corning, catalog #3712) at a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/14/2021
Entry Details
US Patent

TargetOrexin/Hypocretin receptor type 1(Human)
Astrazeneca

US Patent
LigandPNGBDBM479241(US10894789, Compound 185)
Affinity DataIC50: 2nMAssay Description:Measurement of [Ca2+]i using a FLIPR: CHO OX1 or CHO OX2 cells were seeded into black-walled clear-base 384-well plates (Corning, catalog #3712) at a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/14/2021
Entry Details
US Patent

TargetOrexin/Hypocretin receptor type 1(Human)
Astrazeneca

US Patent
LigandPNGBDBM479169(US10894789, Compound 125)
Affinity DataIC50: 2nMAssay Description:Measurement of [Ca2+]i using a FLIPR: CHO OX1 or CHO OX2 cells were seeded into black-walled clear-base 384-well plates (Corning, catalog #3712) at a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/14/2021
Entry Details
US Patent

TargetOrexin/Hypocretin receptor type 1(Human)
Astrazeneca

US Patent
LigandPNGBDBM479230(US10894789, Compound 21)
Affinity DataIC50: 2nMAssay Description:Measurement of [Ca2+]i using a FLIPR: CHO OX1 or CHO OX2 cells were seeded into black-walled clear-base 384-well plates (Corning, catalog #3712) at a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/14/2021
Entry Details
US Patent

TargetOrexin/Hypocretin receptor type 1(Human)
Astrazeneca

US Patent
LigandPNGBDBM479176(US10894789, Compound 123)
Affinity DataIC50: 2nMAssay Description:Measurement of [Ca2+]i using a FLIPR: CHO OX1 or CHO OX2 cells were seeded into black-walled clear-base 384-well plates (Corning, catalog #3712) at a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/14/2021
Entry Details
US Patent

TargetOrexin/Hypocretin receptor type 1(Human)
Astrazeneca

US Patent
LigandPNGBDBM479229(US10894789, Compound 120)
Affinity DataIC50: 2nMAssay Description:Measurement of [Ca2+]i using a FLIPR: CHO OX1 or CHO OX2 cells were seeded into black-walled clear-base 384-well plates (Corning, catalog #3712) at a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/14/2021
Entry Details
US Patent

TargetOrexin/Hypocretin receptor type 1(Human)
Astrazeneca

US Patent
LigandPNGBDBM479268(US10894789, Compound 65)
Affinity DataIC50: 2nMAssay Description:Measurement of [Ca2+]i using a FLIPR: CHO OX1 or CHO OX2 cells were seeded into black-walled clear-base 384-well plates (Corning, catalog #3712) at a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/14/2021
Entry Details
US Patent

TargetOrexin/Hypocretin receptor type 1(Human)
Astrazeneca

US Patent
LigandPNGBDBM479227(US10894789, Compound 211)
Affinity DataIC50: 2nMAssay Description:Measurement of [Ca2+]i using a FLIPR: CHO OX1 or CHO OX2 cells were seeded into black-walled clear-base 384-well plates (Corning, catalog #3712) at a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/14/2021
Entry Details
US Patent

TargetOrexin/Hypocretin receptor type 1(Human)
Astrazeneca

US Patent
LigandPNGBDBM479243(US10894789, Compound 169)
Affinity DataIC50: 2nMAssay Description:Measurement of [Ca2+]i using a FLIPR: CHO OX1 or CHO OX2 cells were seeded into black-walled clear-base 384-well plates (Corning, catalog #3712) at a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/14/2021
Entry Details
US Patent

TargetOrexin/Hypocretin receptor type 1(Human)
Astrazeneca

US Patent
LigandPNGBDBM479201(US10894789, Compound 150)
Affinity DataIC50: 3nMAssay Description:Measurement of [Ca2+]i using a FLIPR: CHO OX1 or CHO OX2 cells were seeded into black-walled clear-base 384-well plates (Corning, catalog #3712) at a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/14/2021
Entry Details
US Patent

TargetOrexin/Hypocretin receptor type 1(Human)
Astrazeneca

US Patent
LigandPNGBDBM479239(US10894789, Compound 30)
Affinity DataIC50: 3nMAssay Description:Measurement of [Ca2+]i using a FLIPR: CHO OX1 or CHO OX2 cells were seeded into black-walled clear-base 384-well plates (Corning, catalog #3712) at a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/14/2021
Entry Details
US Patent

TargetOrexin/Hypocretin receptor type 1(Human)
Astrazeneca

US Patent
LigandPNGBDBM479190(US10894789, Compound 23)
Affinity DataIC50: 3nMAssay Description:Measurement of [Ca2+]i using a FLIPR: CHO OX1 or CHO OX2 cells were seeded into black-walled clear-base 384-well plates (Corning, catalog #3712) at a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/14/2021
Entry Details
US Patent

TargetOrexin/Hypocretin receptor type 1(Human)
Astrazeneca

US Patent
LigandPNGBDBM479308(US10894789, Compound 264)
Affinity DataIC50: 3nMAssay Description:Measurement of [Ca2+]i using a FLIPR: CHO OX1 or CHO OX2 cells were seeded into black-walled clear-base 384-well plates (Corning, catalog #3712) at a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/14/2021
Entry Details
US Patent

TargetOrexin/Hypocretin receptor type 1(Human)
Astrazeneca

US Patent
LigandPNGBDBM479174(US10894789, Compound 63)
Affinity DataIC50: 3nMAssay Description:Measurement of [Ca2+]i using a FLIPR: CHO OX1 or CHO OX2 cells were seeded into black-walled clear-base 384-well plates (Corning, catalog #3712) at a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/14/2021
Entry Details
US Patent

TargetOrexin/Hypocretin receptor type 1(Human)
Astrazeneca

US Patent
LigandPNGBDBM479157(US10894789, Compound 197)
Affinity DataIC50: 3nMAssay Description:Measurement of [Ca2+]i using a FLIPR: CHO OX1 or CHO OX2 cells were seeded into black-walled clear-base 384-well plates (Corning, catalog #3712) at a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/14/2021
Entry Details
US Patent

TargetOrexin/Hypocretin receptor type 1(Human)
Astrazeneca

US Patent
LigandPNGBDBM479202(US10894789, Compound 77)
Affinity DataIC50: 4nMAssay Description:Measurement of [Ca2+]i using a FLIPR: CHO OX1 or CHO OX2 cells were seeded into black-walled clear-base 384-well plates (Corning, catalog #3712) at a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/14/2021
Entry Details
US Patent

TargetOrexin/Hypocretin receptor type 1(Human)
Astrazeneca

US Patent
LigandPNGBDBM479185(US10894789, Compound 26)
Affinity DataIC50: 4nMAssay Description:Measurement of [Ca2+]i using a FLIPR: CHO OX1 or CHO OX2 cells were seeded into black-walled clear-base 384-well plates (Corning, catalog #3712) at a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/14/2021
Entry Details
US Patent

TargetOrexin/Hypocretin receptor type 1(Human)
Astrazeneca

US Patent
LigandPNGBDBM479169(US10894789, Compound 125)
Affinity DataIC50: 4nMAssay Description:Measurement of [Ca2+]i using a FLIPR: CHO OX1 or CHO OX2 cells were seeded into black-walled clear-base 384-well plates (Corning, catalog #3712) at a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/14/2021
Entry Details
US Patent

TargetOrexin/Hypocretin receptor type 1(Human)
Astrazeneca

US Patent
LigandPNGBDBM479168(US10894789, Compound 124)
Affinity DataIC50: 4nMAssay Description:Measurement of [Ca2+]i using a FLIPR: CHO OX1 or CHO OX2 cells were seeded into black-walled clear-base 384-well plates (Corning, catalog #3712) at a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/14/2021
Entry Details
US Patent

TargetOrexin/Hypocretin receptor type 1(Human)
Astrazeneca

US Patent
LigandPNGBDBM479151(US10894789, Compound 33)
Affinity DataIC50: 4nMAssay Description:Measurement of [Ca2+]i using a FLIPR: CHO OX1 or CHO OX2 cells were seeded into black-walled clear-base 384-well plates (Corning, catalog #3712) at a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/14/2021
Entry Details
US Patent

TargetOrexin/Hypocretin receptor type 1(Human)
Astrazeneca

US Patent
LigandPNGBDBM479198(US10894789, Compound 142)
Affinity DataIC50: 4nMAssay Description:Measurement of [Ca2+]i using a FLIPR: CHO OX1 or CHO OX2 cells were seeded into black-walled clear-base 384-well plates (Corning, catalog #3712) at a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/14/2021
Entry Details
US Patent

TargetOrexin/Hypocretin receptor type 1(Human)
Astrazeneca

US Patent
LigandPNGBDBM479150(US10894789, Compound 129 | Compound 185: ((2S,3R)-...)
Affinity DataIC50: 4nMAssay Description:Measurement of [Ca2+]i using a FLIPR: CHO OX1 or CHO OX2 cells were seeded into black-walled clear-base 384-well plates (Corning, catalog #3712) at a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/14/2021
Entry Details
US Patent

TargetOrexin/Hypocretin receptor type 1(Human)
Astrazeneca

US Patent
LigandPNGBDBM479165(US10894789, Compound 29)
Affinity DataIC50: 4nMAssay Description:Measurement of [Ca2+]i using a FLIPR: CHO OX1 or CHO OX2 cells were seeded into black-walled clear-base 384-well plates (Corning, catalog #3712) at a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/14/2021
Entry Details
US Patent

TargetOrexin/Hypocretin receptor type 1(Human)
Astrazeneca

US Patent
LigandPNGBDBM479273(US10894789, Compound 217)
Affinity DataIC50: 4nMAssay Description:Measurement of [Ca2+]i using a FLIPR: CHO OX1 or CHO OX2 cells were seeded into black-walled clear-base 384-well plates (Corning, catalog #3712) at a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/14/2021
Entry Details
US Patent

TargetOrexin/Hypocretin receptor type 1(Human)
Astrazeneca

US Patent
LigandPNGBDBM479272(US10894789, Compound 216)
Affinity DataIC50: 4nMAssay Description:Measurement of [Ca2+]i using a FLIPR: CHO OX1 or CHO OX2 cells were seeded into black-walled clear-base 384-well plates (Corning, catalog #3712) at a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/14/2021
Entry Details
US Patent

TargetOrexin/Hypocretin receptor type 1(Human)
Astrazeneca

US Patent
LigandPNGBDBM479178(US10894789, Compound 64)
Affinity DataIC50: 4nMAssay Description:Measurement of [Ca2+]i using a FLIPR: CHO OX1 or CHO OX2 cells were seeded into black-walled clear-base 384-well plates (Corning, catalog #3712) at a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/14/2021
Entry Details
US Patent

TargetOrexin/Hypocretin receptor type 1(Human)
Astrazeneca

US Patent
LigandPNGBDBM479238(US10894789, Compound 31)
Affinity DataIC50: 4nMAssay Description:Measurement of [Ca2+]i using a FLIPR: CHO OX1 or CHO OX2 cells were seeded into black-walled clear-base 384-well plates (Corning, catalog #3712) at a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/14/2021
Entry Details
US Patent

TargetOrexin/Hypocretin receptor type 1(Human)
Astrazeneca

US Patent
LigandPNGBDBM479144(US10894789, Compound 200)
Affinity DataIC50: 4nMAssay Description:Measurement of [Ca2+]i using a FLIPR: CHO OX1 or CHO OX2 cells were seeded into black-walled clear-base 384-well plates (Corning, catalog #3712) at a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/14/2021
Entry Details
US Patent

TargetOrexin/Hypocretin receptor type 1(Human)
Astrazeneca

US Patent
LigandPNGBDBM479191(US10894789, Compound 25)
Affinity DataIC50: 4nMAssay Description:Measurement of [Ca2+]i using a FLIPR: CHO OX1 or CHO OX2 cells were seeded into black-walled clear-base 384-well plates (Corning, catalog #3712) at a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/14/2021
Entry Details
US Patent

TargetOrexin/Hypocretin receptor type 1(Human)
Astrazeneca

US Patent
LigandPNGBDBM479175(US10894789, Compound 134)
Affinity DataIC50: 4nMAssay Description:Measurement of [Ca2+]i using a FLIPR: CHO OX1 or CHO OX2 cells were seeded into black-walled clear-base 384-well plates (Corning, catalog #3712) at a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/14/2021
Entry Details
US Patent

TargetOrexin/Hypocretin receptor type 1(Human)
Astrazeneca

US Patent
LigandPNGBDBM479159(US10894789, Compound 174)
Affinity DataIC50: 4nMAssay Description:Measurement of [Ca2+]i using a FLIPR: CHO OX1 or CHO OX2 cells were seeded into black-walled clear-base 384-well plates (Corning, catalog #3712) at a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/14/2021
Entry Details
US Patent

TargetOrexin/Hypocretin receptor type 1(Human)
Astrazeneca

US Patent
LigandPNGBDBM479252(US10894789, Compound 51)
Affinity DataIC50: 4nMAssay Description:Measurement of [Ca2+]i using a FLIPR: CHO OX1 or CHO OX2 cells were seeded into black-walled clear-base 384-well plates (Corning, catalog #3712) at a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/14/2021
Entry Details
US Patent

TargetOrexin/Hypocretin receptor type 1(Human)
Astrazeneca

US Patent
LigandPNGBDBM479158(US10894789, Compound 175)
Affinity DataIC50: 4nMAssay Description:Measurement of [Ca2+]i using a FLIPR: CHO OX1 or CHO OX2 cells were seeded into black-walled clear-base 384-well plates (Corning, catalog #3712) at a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/14/2021
Entry Details
US Patent

TargetOrexin/Hypocretin receptor type 1(Human)
Astrazeneca

US Patent
LigandPNGBDBM479266(US10894789, Compound 67)
Affinity DataIC50: 5nMAssay Description:Measurement of [Ca2+]i using a FLIPR: CHO OX1 or CHO OX2 cells were seeded into black-walled clear-base 384-well plates (Corning, catalog #3712) at a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/14/2021
Entry Details
US Patent

TargetOrexin/Hypocretin receptor type 1(Human)
Astrazeneca

US Patent
LigandPNGBDBM479172(US10894789, Compound 137)
Affinity DataIC50: 5nMAssay Description:Measurement of [Ca2+]i using a FLIPR: CHO OX1 or CHO OX2 cells were seeded into black-walled clear-base 384-well plates (Corning, catalog #3712) at a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/14/2021
Entry Details
US Patent

TargetOrexin/Hypocretin receptor type 1(Human)
Astrazeneca

US Patent
LigandPNGBDBM479297(US10894789, Compound 242)
Affinity DataIC50: 5nMAssay Description:Measurement of [Ca2+]i using a FLIPR: CHO OX1 or CHO OX2 cells were seeded into black-walled clear-base 384-well plates (Corning, catalog #3712) at a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/14/2021
Entry Details
US Patent

TargetOrexin/Hypocretin receptor type 1(Human)
Astrazeneca

US Patent
LigandPNGBDBM479179(US10894789, Compound 122)
Affinity DataIC50: 5nMAssay Description:Measurement of [Ca2+]i using a FLIPR: CHO OX1 or CHO OX2 cells were seeded into black-walled clear-base 384-well plates (Corning, catalog #3712) at a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/14/2021
Entry Details
US Patent

TargetOrexin/Hypocretin receptor type 1(Human)
Astrazeneca

US Patent
LigandPNGBDBM479271(US10894789, Compound 215)
Affinity DataIC50: 5nMAssay Description:Measurement of [Ca2+]i using a FLIPR: CHO OX1 or CHO OX2 cells were seeded into black-walled clear-base 384-well plates (Corning, catalog #3712) at a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/14/2021
Entry Details
US Patent

TargetOrexin/Hypocretin receptor type 1(Human)
Astrazeneca

US Patent
LigandPNGBDBM479192(US10894789, Compound 121)
Affinity DataIC50: 5nMAssay Description:Measurement of [Ca2+]i using a FLIPR: CHO OX1 or CHO OX2 cells were seeded into black-walled clear-base 384-well plates (Corning, catalog #3712) at a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/14/2021
Entry Details
US Patent

TargetOrexin/Hypocretin receptor type 1(Human)
Astrazeneca

US Patent
LigandPNGBDBM479161(US10894789, Compound 147)
Affinity DataIC50: 5nMAssay Description:Measurement of [Ca2+]i using a FLIPR: CHO OX1 or CHO OX2 cells were seeded into black-walled clear-base 384-well plates (Corning, catalog #3712) at a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/14/2021
Entry Details
US Patent

TargetOrexin/Hypocretin receptor type 1(Human)
Astrazeneca

US Patent
LigandPNGBDBM479237(US10894789, Compound 70)
Affinity DataIC50: 5nMAssay Description:Measurement of [Ca2+]i using a FLIPR: CHO OX1 or CHO OX2 cells were seeded into black-walled clear-base 384-well plates (Corning, catalog #3712) at a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/14/2021
Entry Details
US Patent

TargetOrexin/Hypocretin receptor type 1(Human)
Astrazeneca

US Patent
LigandPNGBDBM479197(US10894789, Compound 167)
Affinity DataIC50: 5nMAssay Description:Measurement of [Ca2+]i using a FLIPR: CHO OX1 or CHO OX2 cells were seeded into black-walled clear-base 384-well plates (Corning, catalog #3712) at a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/14/2021
Entry Details
US Patent

TargetOrexin/Hypocretin receptor type 1(Human)
Astrazeneca

US Patent
LigandPNGBDBM479186(US10894789, Compound 32)
Affinity DataIC50: 6nMAssay Description:Measurement of [Ca2+]i using a FLIPR: CHO OX1 or CHO OX2 cells were seeded into black-walled clear-base 384-well plates (Corning, catalog #3712) at a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/14/2021
Entry Details
US Patent

TargetOrexin/Hypocretin receptor type 1(Human)
Astrazeneca

US Patent
LigandPNGBDBM479156(US10894789, Compound 177)
Affinity DataIC50: 6nMAssay Description:Measurement of [Ca2+]i using a FLIPR: CHO OX1 or CHO OX2 cells were seeded into black-walled clear-base 384-well plates (Corning, catalog #3712) at a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/14/2021
Entry Details
US Patent

TargetOrexin/Hypocretin receptor type 1(Human)
Astrazeneca

US Patent
LigandPNGBDBM479171(US10894789, Compound 138)
Affinity DataIC50: 6nMAssay Description:Measurement of [Ca2+]i using a FLIPR: CHO OX1 or CHO OX2 cells were seeded into black-walled clear-base 384-well plates (Corning, catalog #3712) at a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/14/2021
Entry Details
US Patent

TargetOrexin/Hypocretin receptor type 1(Human)
Astrazeneca

US Patent
LigandPNGBDBM479265(US10894789, Compound 49)
Affinity DataIC50: 6nMAssay Description:Measurement of [Ca2+]i using a FLIPR: CHO OX1 or CHO OX2 cells were seeded into black-walled clear-base 384-well plates (Corning, catalog #3712) at a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/14/2021
Entry Details
US Patent

TargetOrexin/Hypocretin receptor type 1(Human)
Astrazeneca

US Patent
LigandPNGBDBM479155(US10894789, Compound 186)
Affinity DataIC50: 6nMAssay Description:Measurement of [Ca2+]i using a FLIPR: CHO OX1 or CHO OX2 cells were seeded into black-walled clear-base 384-well plates (Corning, catalog #3712) at a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/14/2021
Entry Details
US Patent

Displayed 1 to 50 (of 334 total ) | Next | Last >>
Jump to: